Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Troglitazone × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Sarcoma 1 Liposarcoma 1

Interventions

Radiotherapy 136 Cyclophosphamide 133 Temozolomide 116 Doxorubicin 99 Filgrastim 68 Ifosfamide 64 Gemcitabine 58 Etoposide 55 Bevacizumab 51 fludarabine phosphate 50 Imatinib Mesylate 50 Irinotecan 46 pembrolizumab 45 Peripheral Blood Stem Cell Transplantation 45 pazopanib 43 Magnetic Resonance Spectroscopy 40 Carboplatin 40 Busulfan 40 Methotrexate 39 Vincristine 38 Melphalan 37 Surgical Procedures, Operative 36 Nivolumab 36 Cisplatin 36 Radiation 33 Blood Specimen Collection 33 Mycophenolic Acid 31 Cyclosporine 31 Docetaxel 29 Trabectedin 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003058 2017-02-13

Troglitazone in Treating Patients With Liposarcoma

Dana-Farber Cancer Institute

Phase 2 Completed

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡